These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37964179)

  • 1. Acetaminophen-induced liver injury at therapeutic doses in a young adult: a case report.
    Tajirika S; Yamamoto M; Matsushita T; Yamada T; Shimizu M
    Clin J Gastroenterol; 2024 Feb; 17(1):130-136. PubMed ID: 37964179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
    Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM.
    Shakhashiro M; Crasta R; Javed F
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37748817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
    Studentova H; Volakova J; Spisarova M; Zemankova A; Aiglova K; Szotkowski T; Melichar B
    BMC Gastroenterol; 2022 Feb; 22(1):49. PubMed ID: 35123392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
    Teschke R; Danan G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roussel-Uclaf hepatotoxicity causality assessment method in the context of diagnostic suspicion of drug-induced liver damage: Is it still valid?
    Sánchez Luque CB
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):453-454. PubMed ID: 38097435
    [No Abstract]   [Full Text] [Related]  

  • 7. Answer to Sánchez-Luque et al. regarding "The Roussel-Uclaf hepatotoxicity causality assessment method in the context of diagnostic suspicion of drug-induced liver damage: Is it still valid?".
    Ardila-Suárez OM; Oriz-Benjumea L; Arteta AA; Guevara-Casallas LG
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):454. PubMed ID: 38097434
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.
    Taneja S; Kumar P; Rathi S; Duseja A; Singh V; Dhiman RK; Chawla YK
    Ann Hepatol; 2017; 16(5):818-821. PubMed ID: 28809737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
    Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen.
    Seifert SA; Kovnat D; Anderson VE; Green JL; Dart RC; Heard KJ
    Clin Toxicol (Phila); 2016 Mar; 54(3):282-5. PubMed ID: 26763284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
    Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
    Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Hepatotoxicity: Causality Assessment.
    Caines A; Moonka D
    Clin Liver Dis; 2020 Feb; 24(1):25-35. PubMed ID: 31753248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highlights of the drug-induced liver injury literature for 2021.
    Woo SM; Alhaqqan DM; Gildea DT; Patel PA; Cundra LB; Lewis JH
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):767-785. PubMed ID: 35839342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.
    Rochon J; Protiva P; Seeff LB; Fontana RJ; Liangpunsakul S; Watkins PB; Davern T; McHutchison JG;
    Hepatology; 2008 Oct; 48(4):1175-83. PubMed ID: 18798340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver failure after recommended doses of acetaminophen in patients with myopathies.
    Ceelie I; James LP; Gijsen V; Mathot RA; Ito S; Tesselaar CD; Tibboel D; Koren G; de Wildt SN
    Crit Care Med; 2011 Apr; 39(4):678-82. PubMed ID: 21242792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
    Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
    Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAM.
    Mathavan A; Mathavan A; Krekora U; Daily K
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37142282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.